Guidance Issued for Reducing ASCVD Risk in Hypertriglyceridemia
Factors to consider include evaluation of secondary causes, optimization of diet and lifestyle interventions, implementation of statin therapy
Hyperlipoproteinemias
MPR Weekly Dose Podcast Episode 87
This week we have news of the FDA requesting a change to statin prescribing labels, a new vaccine for streptococcus pneumoniae, a new plaque psoriasis cream, a stem cell therapy gets fast tracked as a possible Parkinson disease treatment, and there’s a new treatment approved for Progressive Familial Intrahepatic Cholestasis.
FDA Requests Removal of Pregnancy Contraindication for Statins
The FDA conducted a comprehensive review of all available data associated with the use of statins during pregnancy.
Statin Use Linked to Reduced Death Risk in Hospitalized COVID-19 Patients
Study authors analyzed data from 10,541 hospitalized patients with active COVID-19 disease to evaluate the relationship between the use of statins and COVID-19 outcomes.
Cholesterol Management Supplement Found to Contain Undeclared Rx Ingredient
Cholestene, a dietary supplement marketed for cholesterol management, has been found to contain a hidden drug ingredient, according to the Food and Drug Administration. Based on laboratory analysis, the product, which is sold on various websites and in some retail stores, has been found to contain lovastatin, an HMG-CoA reductase inhibitor (statin). Consuming a supplement…
Impact of Age Examined for Ticagrelor Monotherapy After PCI
Ticagrelor monotherapy reduces bleeding without increasing ischemic events among patients undergoing PCI
Ticagrelor, Prasugrel Compared in ACS Treated With PCI
Prespecified subgroup analysis of data from a randomized clinical trial suggest that a prasugrel-based strategy is preferable
Risk of Muscle Problems Based on Statin Therapy Intensity Investigated
Small increases in the risk for statin-associated muscle symptoms were observed for patients on high-intensity therapy.
Plant-Centered Diet May Lower LDL Cholesterol, CVD Risk
Diet low in saturated fat also associated with lower LDL-cholesterol, but not long-term risk for cardiovascular disease
Providers Less Likely to Prescribe Statins in the Afternoon
Even for at-risk patients, primary care providers are less likely to prescribe during afternoon appointments
